Page 8 - Les Meilleurs doctors pour votre IRM cérébrale - TOP 230 des médecins

ÉDUCATION:

2014 UNIVERSITÉ ADNAN MENDERES FACULTÉ DE MÉDECINE, SANTÉ ET MALADIES INFANTILES, NEUROLOGIE INFANTILE

2011 Hôpital d'éducation et de recherche d'IZMIR, santé et maladies infantiles

2011 Hôpital d'enseignement et de recherche Izmir Tepecik, santé et maladies infantiles

2004 UNIVERSITÉ DICLE, FACULTÉ DE MÉDECINE

EXPÉRIENCE:

Hôpital Medipol d'Istanbul 2018

2017 - 2018 Hôpital d'enseignement et de recherche de Kartal

2014 - 2016 Hôpital d'État de Denizli

2011 - 2014 Hôpital de la Faculté de médecine de l'Université Aydin Adnan Menderes

2006 - 2011 Hôpital d'enseignement et de recherche Izmir Tepecik

2011 Hôpital d'enseignement et de recherche d'Izmir

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Éducation

2019

Faculté de médecine d'Istanbul, Electroneurophysiologie

2005

Faculté de médecine, neurologie, Université Cerrahpasa d'Istanbul

1998

Université Cerrahpasa d'Istanbul, Faculté de médecine

Expérience

2017 - 2019

Hôpital privé Adatip Kurtkoy

2016

TND – Prix Schering-Plough des actes de l'année

2015 - 2017

Hôpital privé Gaziosmanpaşa de l'Université Yeni Yüzyıl d'Istanbul

2015 - 2015

Hôpital de formation et de recherche Şişli Hamidiye Etfal

2005 - 2014

Hôpital privé Avicenna Hope

2015 – 2019 Faculté de médecine Cerrahpasa de l'Université d'Istanbul

2019 – Hôpital universitaire Medipol Pendik

Publications

1- Yüz Ağrılarında Trijumeau SEP Uygulaması ; Yüksek Lisans Tezi

2- Glial Tümörlerde P53, PTEN et EGRF Pozitifliğinin İmmunohistokimyasal ; Uzmanlik Tezi

3- Deux frères et sœurs atteints d'homocystinurie présentant une dystonie et un syndrome parkinsonien

4- Absence d'association entre les polymorphismes du gène IL-1ß/? et l'épilepsie du lobe temporal avec sclérose hippocampique

5- Troubles psychogènes du mouvement chez deux enfants

6- Épilepsie du lobe temporel et sclérose hippocampique Hastalarda İnterlökin 1-ß et İnterlökin 1-? Gen Polimorphizminin Analizi

7- Hippocampe Skleroza Bağlı Épilepsie mésiale du lobe temporal ou Interlökin 1-ß et Interlökin 1-? Gen Polimorfizmi İlişkisinin Araştırılması

Dr. Ela Simay Zengin is a neurologist. She completed her medical training at Dokuz Eylül University, Başkent University, and Acıbadem University. She has worked at Bitlis Tatvan, Sirnak, and Cizre State Hospitals.

Dr. Zengin treats Alzheimer’s disease, epilepsy, migraines, multiple sclerosis, Parkinson’s disease, and stroke. She uses advanced treatments, including apomorphine pump therapy, botulinum toxin injections, and migraine vaccines.

She is a member of the Turkish Neurology Association, American Academy of Neurology, European Academy of Neurology, and International Parkinson and Movement Disorder Society.

Dr. Ulvi Samadzade is a neurologist with training from Azerbaijan State Medical University, Gazi University, and Dokuz Eylul University Hospital. He diagnoses and treats neurological disorders such as Alzheimer’s disease, epilepsy, movement disorders, stroke, migraine, and multiple sclerosis.

Dr. Samadzade uses advanced treatments, including botulinum toxin injections, intravenous immunoglobulin (IVIG) therapy, migraine vaccines, and plasmapheresis. He practices at İzmir University of Economics Medical Point Hospital.

He is a member of several professional organizations. These include the Multiple Sclerosis Research Association, Turkish Neurological Society, European Academy of Neurology, and the International Parkinson and Movement Disorder Society (MDS).

Dr. Evren Sandal is a specialist in Brain and Neurosurgery. He completed his medical degree at Ege University Faculty of Medicine. He finished his neurosurgery training in 2015. Dr. Sandal focuses on skull base, craniocervical junction, and neurovascular surgery. He has extensive experience in these fields.

Dr. Sandal has worked at the Health Sciences University Tepecik Training and Research Hospital. He also contributed to laboratory and clinical studies in skull base and cerebral bypass surgery at the University of Wisconsin, USA. He has collaborated with experts such as Prof. Dr. M. Sedat Çağlı and Prof. Başkaya. These experiences have strengthened his skills in complex neurosurgical procedures.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Alper Karaoglan is a Professor of Neurosurgery at Memorial Bodrum Hospital. He has many years of experience in neurosurgery. He worked at Maltepe University Faculty of Medicine and Taksim Training and Research Hospital in Istanbul. Since 2008, he has held the positions of Professor, Associate Professor, and Assistant Professor in neurosurgery.

Dr. Karaoglan is a member of the Turkish Medical Association and the Turkish Neurosurgical Society. He has received several awards. These include the Best Paper Award at the Turkish Neurosurgical Society Scientific Congress in 2005 for his research on resveratrol’s protective effects after subarachnoid hemorrhage, and the Young Neurosurgeon Encouragement Award in 2008.

Dr. Shady Mohammed El‑sebai is an interventional radiologist and diagnostic imaging consultant. He is the Consultant and Chief of Interventional Radiology at Sheaf El Orman Oncology Hospital (2021–present). He is also Chief of the Interventional Radiology Unit at the National Cancer Institute, Cairo University (2022–present). He has been a Lecturer in interventional radiology at the National Cancer Institute since 2018. Earlier posts include assistant lecturer and specialist, radiology resident, specialist at Khartoum Breast Care Centre, and specialist and consultant at Techno Scan.

Expertise includes CT‑ and US‑guided true‑cut biopsies and FNAC; transarterial chemoembolization for HCC and for liver, renal, and soft‑tissue tumors; percutaneous nephrostomy and ureteric stents; pigtail drainage; and RF or microwave ablation of hepatic, bone, lung, and thyroid lesions. He also performs PTD and biliary stents; uterine artery embolization; coiling for pelvic varicosities and varicocele; varicose vein ablation and sclerotherapy; and breast procedures (biopsy, markers, wire localization, Mammotome). He is skilled in US, CT, and MRI.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Naphat Sirinimnualkul, M.D. (Dr. Ken), is a psychiatrist and clinical instructor at the Excellence Center for Sleep Disorders, King Chulalongkorn Memorial Hospital (2022–present). He previously served as a psychiatrist and clinical instructor at the General Police Hospital (Aug–Dec 2021). He completed his psychiatry residency at Chulalongkorn University (2018–2021).

Board/education: Diploma, Board of General Psychiatry, Thai General Medical Council (2018–2021). Graduate Diploma in Clinical Sciences (Psychiatry), Chulalongkorn University (2018–2021). M.D., Second Class Honors, Chulalongkorn University (2011–2017). Training: Cognitive Behavioral Therapy for Insomnia.

Expertise: sleep medicine, neuropsychiatry, consultation-liaison psychiatry, and psychopharmacology. He focuses on the interface between sleep and mood disorders.

Dr. Tara Rak-areekul is a neurologist focused on cognitive neurology. She is a fellow at King Chulalongkorn Memorial Hospital. She completed her neurology residency there and served as Chief of Academic in 2023. She holds an MD from Chulalongkorn University (Second Class Honors) and a Higher Graduate Diploma in Clinical Sciences. She is certified in NIHSS (2022) and the Thai Stroke Society Acute Stroke Treatment Course.

Key achievements include first rank in the National Formative Neurological Exam (2023). She won the Epilepsy Quiz Tournament (2023). She was first runner-up at the Neurology Tournaments at NST Midyear 2023 and the Chula Neuroscience Forum 2022. Her research includes AAIC poster presentations (2024, 2025). Ongoing work covers Alzheimer’s biomarkers (MDS‑OAβ and p‑tau217), the Thai clinical adaptation of HippoCamera, and a chapter on behavioral and psychological symptoms of dementia (BPSD).

Somjet Tosamran, MD, is a neurologist. Dr. Tosamran is a fellow in epilepsy at the Neurology Division, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand (2024–present). Dr. Tosamran completed a neurology residency at the same hospital (2021–2024). Earlier training includes internships at Charoenkrung Pracharak Hospital and Sakaeo Crown Prince Hospital.

Accreditations and education: Neurologist certification, King Chulalongkorn Memorial Hospital (2024). Master of Science in Internal Medicine, Faculty of Medicine, Chulalongkorn University (2024). Doctor of Medicine, First Class Honors, Faculty of Medicine, Chulalongkorn University (2018).

Expérience

2019 – 2019

• Université d'Insubrie, Varèse, Italie,

Faculté de médecine de l'Université d'Insubrie

2015

• UNIVERSITÉ DE MERSİN/FACULTÉ DE MÉDECINE, MÉDECIN, CONFÉRENT

2013 – 2015

• HÔPITAL PRIVÉ ACIBADEM D'ANKARA

2010 – 2012

• HÔPITAL DE FORMATION ET DE RECHERCHE DE DIYARBAKIR,

2002 – 2003

• 1ER BATAILLON D'ENTRAINEMENT PRIVÉ D'AYDIN

Éducation

2010

• Faculté de médecine de l'Université d'Ankara, spécialiste en chirurgie cérébrale

1992

• UNIVERSITÉ DE GAZI, FACULTÉ DE MÉDECINE

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Diagnostic et traitements de la maladie de Parkinson

Diagnostic et traitements de la maladie d'Alzheimer

Épilepsie (épileptique)

EEG et traitement

Diagnostic et traitements des maladies musculaires et nerveuses

Diagnostic et traitement du vertige

Syndrome des jambes sans repos

Diagnostic et traitement de l'AVC (paralysie cérébrale)

Hôpital d'État de Bartın (2007-2009)

Hôpital VM Medical Park Samsun (2009-2017)

Hôpital VM Medical Park Samsun - Médecin-chef adjoint (2019-2021)

Hôpital d'enseignement et de recherche de Samsun (2021-2022)

Hôpital d'État de Çarşamba

Hôpital privé Atasam Samsun (2022-2024)

Université Technique de Karadeniz (1989-1995)

Faculté de médecine de l'Université Ondokuz Mayis (2001-2006)

Le médecin est un neurologue très expérimenté, spécialisé dans le diagnostic et le traitement d'un large éventail de troubles neurologiques. Avec plus de 15 ans d'expérience clinique, le médecin a contribué à de nombreuses études de recherche et a été publié dans plusieurs revues médicales prestigieuses. Le médecin a été reconnu pour ses approches innovantes en matière de soins aux patients et a reçu plusieurs prix pour l'excellence en neurologie. De plus, le médecin est certifié par le conseil et participe activement à l'éducation médicale continue pour rester à jour avec les dernières avancées dans le domaine.<\/p>

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.